Adverse events associated with treatment · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: quality of life · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs · ulceration and other skin changes caused by nerve damage in leprosy
1 finding from 1 review
Adverse events · Children who were regular dental attenders with caries-free first or second primary molars (public health service clinic, Brazil)
The review found no eligible studies for this question.
1 finding from 1 review
Progression of non-cavitated enamel caries · Children who were regular dental attenders with caries-free first or second primary molars (public health service clinic, Brazil)
The review found no eligible studies for this question.
1 finding from 1 review
Development of >=1 new carious lesion (caries incidence) · Children who were regular dental attenders with caries-free first or second primary molars (public health service clinic, Brazil)
The review found no eligible studies for this question.
1 finding from 1 review
Retention of sealant (complete or partial retention) · Children who were regular dental attenders with caries-free first or second primary molars (public health service clinic, Brazil)
1 finding from 1 review
Effect estimate not calculable. All sealants were completely or partially retained; 40 (1 RCT). Flowable composite: 39/40 completely retained (1 partially lost) at 6 months; resin-based: 33 completely and 7 partially…
1 study · 40 participants
Low
Systolic blood pressure · adult participants
1 finding from 1 review
Diastolic blood pressure · adult participants
1 finding from 1 review
Heart rate · adult participants
1 finding from 1 review
Residual renal function (GFR; · PD patients
1 finding from 1 review
Urine volume ( · PD patients
1 finding from 1 review
Peritoneal ultrafiltration ‐ 4 hours (mL/4 hours) ( · PD patients
1 finding from 1 review
Peritoneal solute transport rate (4‐hour dialysis:plasma creatinine) ( · PD patients
1 finding from 1 review
Peritonitis · PD patients
Low GDP (all buffer types) showed no clear difference in peritonitis rate (episodes/total patient‐months) (up to 24 months) compared with standard glucose dialysate (low certainty).
1 finding from 1 review
Technique failure (death‐censored) ( · PD patients
Low GDP (all buffer types) showed no clear difference in technique failure (death‐censored) ( compared with standard glucose dialysate (low certainty).
1 finding from 1 review
Death (all causes) ( · PD patients
Low GDP (all buffer types) showed no clear difference in death (all causes) ( compared with standard glucose dialysate (low certainty).
1 finding from 1 review
RR 0.73 [0.47, 1.14]
1229 participants
Low
Laxation response: risk of spontaneous rescue‐free bowel movements in the short terma · people receiving palliative care irrespective of whether they had cancer with opioid‐induced bowel dysfunction
Methylnaltrexone lower dose showed no clear difference in laxation response: risk of spontaneous rescue‐free bowel… compared with higher dose (low certainty).
1 finding from 1 review
Laxation response: risk of spontaneous rescue‐free bowel movements in the medium termb · people receiving palliative care irrespective of whether they had cancer with opioid‐induced bowel dysfunction
It is very uncertain whether methylnaltrexone lower dose changes laxation response: risk of spontaneous rescue‐free bowel… compared with higher dose (very low certainty).
1 finding from 1 review